✦ LIBER ✦

Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial

✍ Scribed by Chadi Nabhan; Timothy M. Lestingi; Angel Galvez; Kathy Tolzien; Susan K. Kelby; Dean Tsarwhas; Steven Newman; Jacob D. Bitran

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study evaluating the toxicity

✍ Kruczek, K; Ratterman, M; Tolzien, K; Sulo, S; Lestingi, T M; Nabhan, C 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 166 KB

Lenalidomide Monotherapy in Chemotherapy

✍ Nabhan, Chadi; Patel, Anand; Villines, Dana; Tolzien, Kathy; Kelby, Susan K.; Le 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 263 KB

126 Long term safety and efficacy in a r

✍ A.J. Armstrong; J.R. Gingrich; M Häggman; W.M. Stadler; J.E. Damber; L. Belkoff; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 20 KB

A randomized phase II efficacy and safet

✍ Arun A. Azad,Emma K. Beardsley,Sebastian J. Hotte… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 188 KB

Abiraterone acetate plus prednisone vers

✍ Basch, Ethan; Autio, Karen; Ryan, Charles J; Mulders, Peter; Shore, Neal; Kheoh, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 231 KB

P-533 Single agent weekly paclitaxel che

✍ Massuti, B.; Camps, C.; Garrido, P.; Viñolas, N.; Barcelo, J.; Barneto, I.; Guil 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 286 KB